Pfizer
PFE
PFE
2,895 hedge funds and large institutions have $92.9B invested in Pfizer in 2025 Q4 according to their latest regulatory filings, with 320 funds opening new positions, 1,074 increasing their positions, 1,264 reducing their positions, and 169 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
11% less funds holding in top 10
Funds holding in top 10: 35 → 31 (-4)
15% less repeat investments, than reductions
Existing positions increased: 1,074 | Existing positions reduced: 1,264
19% less call options, than puts
Call options by funds: $2.6B | Put options by funds: $3.2B
Holders
2,895
Holding in Top 10
31
Calls
$2.6B
Puts
$3.2B
Top Buyers
| 1 | +$362M | |
| 2 | +$342M | |
| 3 | +$189M | |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$184M |
| 5 |
Goldman Sachs
New York
|
+$183M |
Top Sellers
| 1 | -$450M | |
| 2 | -$223M | |
| 3 | -$211M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$167M |
| 5 |
Jane Street
New York
|
-$146M |
